The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
More than 10,000 scientific publications containing EUDRAGIT
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
The validations confirm the completion of the applications and commence the scientific review process
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The facility will accommodate over 1,500 employees
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Subscribe To Our Newsletter & Stay Updated
